Balance Sheet - Tyra Biosciences, Inc. (TYRA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 256.00 | 341.44 | 203.47 | 251.21 | 302.18 | 15.22 | 0.11 |
| Accounts receivable, net | 2.00 | 0.70 | |||||
| Other current assets | 9.45 | 4.02 | 8.20 | 6.08 | 1.88 | 0.06 | 0.02 |
| Total current assets | 265.45 | 347.46 | 211.67 | 257.29 | 304.06 | 15.28 | 0.13 |
| Total non-current assets | 17.16 | 16.10 | 14.19 | 8.89 | 2.64 | 0.73 | 0.40 |
| Total assets | 282.61 | 363.56 | 225.86 | 266.18 | 306.70 | 16.01 | 0.53 |
| Total current liabilities | 18.09 | 14.59 | 15.33 | 5.70 | 3.62 | 1.86 | 5.16 |
| Total non-current liabilities | 5.34 | 5.81 | 6.26 | 2.65 | 1.35 | 27.79 | 0.11 |
| Total liabilities | 23.43 | 20.41 | 21.60 | 8.35 | 4.96 | 29.65 | 5.27 |
| Total stockholders' equity | 259.18 | 343.15 | 204.26 | 257.83 | 301.74 | -13.64 | -4.74 |
| Common shares outstanding | 60 | 57 | 43 | 42 | 41 | 43 | 43 |
Show Quarterly Balance Sheet
Balance Sheet - Tyra Biosciences, Inc. (TYRA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 383.47 | 256.00 | 274.92 | 296.27 | 318.94 | 341.44 | 360.13 | 373.80 | 382.46 | 203.47 | 215.65 | 232.41 | 241.70 | 251.21 | 263.21 | 275.11 | 292.50 | 302.18 | 312.82 | 135.20 | 140.64 | 15.22 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 2.20 | 1.70 | 1.80 | 2.00 | 1.90 | 1.90 | 1.50 | 0.70 | |||||||||||||||||
| Other current assets | 11.15 | 9.45 | 4.09 | 4.18 | 3.82 | 4.02 | 3.58 | 4.78 | 8.32 | 8.20 | 8.98 | 8.33 | 5.01 | 6.08 | 4.26 | 2.19 | 1.53 | 1.88 | 0.68 | 0.22 | 0.19 | 0.06 | 0.02 | ||
| Total current assets | 394.61 | 265.45 | 281.22 | 302.16 | 324.57 | 347.46 | 365.61 | 378.57 | 390.78 | 211.67 | 224.63 | 240.75 | 246.71 | 257.29 | 267.47 | 277.30 | 294.03 | 304.06 | 313.50 | 135.42 | 140.83 | 15.28 | 15.28 | ||
| Total non-current assets | 17.43 | 17.16 | 20.63 | 19.34 | 18.91 | 16.10 | 14.98 | 13.89 | 13.96 | 14.19 | 13.73 | 9.27 | 8.35 | 8.89 | 8.51 | 9.82 | 4.95 | 2.64 | 2.47 | 4.50 | 0.98 | 0.73 | |||
| Total assets | 412.04 | 282.61 | 301.85 | 321.50 | 343.48 | 363.56 | 380.59 | 392.46 | 404.74 | 225.86 | 238.36 | 250.01 | 255.06 | 266.18 | 275.99 | 287.12 | 298.97 | 306.70 | 315.97 | 139.92 | 141.81 | 16.01 | |||
| Total current liabilities | 19.26 | 18.09 | 15.88 | 13.77 | 14.25 | 14.59 | 12.37 | 10.38 | 8.72 | 15.33 | 10.15 | 5.41 | 3.68 | 5.70 | 5.49 | 5.46 | 4.90 | 3.62 | 4.77 | 3.75 | 1.54 | 1.86 | 1.86 | ||
| Total non-current liabilities | 5.21 | 5.34 | 5.46 | 5.58 | 5.70 | 5.81 | 5.93 | 6.04 | 6.15 | 6.26 | 6.04 | 6.04 | 2.58 | 2.65 | 2.74 | 2.81 | 2.89 | 1.35 | 1.47 | 158.84 | 157.80 | 27.79 | |||
| Total liabilities | 24.47 | 23.43 | 21.34 | 19.35 | 19.94 | 20.41 | 18.30 | 16.42 | 14.86 | 21.60 | 16.19 | 11.44 | 6.27 | 8.35 | 8.23 | 8.27 | 7.79 | 4.96 | 6.24 | 162.59 | 159.33 | 29.65 | |||
| Total stockholders' equity | 387.58 | 259.18 | 280.51 | 302.15 | 323.53 | 343.15 | 362.29 | 376.04 | 389.88 | 204.26 | 222.17 | 238.57 | 248.79 | 257.83 | 267.76 | 278.85 | 291.18 | 301.74 | 309.73 | -22.67 | -17.52 | -13.64 | |||
| Common shares outstanding | 62 | 60 | 60 | 60 | 59 | 59 | 59 | 59 | 52 | 43 | 43 | 43 | 42 | 42 | 42 | 42 | 42 | 41 | 9 | 37 | 22 | 22 | 22 | 1 | 1 |